Predict your next investment

Corporation
HEALTHCARE | Drug Development
arvelletx.com

See what CB Insights has to offer

Business Relationships

7

Service Providers

3

Arvelle Therapeutics Service Providers

3 Service Providers

Arvelle Therapeutics has 3 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Acquired

Management Consultants

Financial Advisor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Subscribe to see more

Associated Rounds

Acquired

Subscribe to see more

Subscribe to see more

Provider Type

Management Consultants

Subscribe to see more

Subscribe to see more

Service Type

Financial Advisor

Subscribe to see more

Subscribe to see more

Partnership data by VentureSource

Arvelle Therapeutics Partners & Customers

7 Partners and customers

Arvelle Therapeutics has 7 strategic partners and customers. Arvelle Therapeutics recently partnered with Arvato Systems on April 4, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

4/1/2021

Vendor

Arvato Systems

Germany

Arvelle Therapeutics implements serialization solution "Arvato CSDB Arvelle Therapeutics Committed to Patients and Healthcare Professionals through the Implementation of the IT Solution "Arvato CSDB".

Arvelle Therapeutics International GmbH entered into a partnership with Arvato Systems for the serialization of `` Cenobamate '' , a potential anti-seizure investigational drug in Europe .

1

1/4/2021

Licensor

SK Biopharmaceuticals

South Korea

Subscribe to see more

Subscribe to see more

10

8/17/2020

Partner

Durbin

United Kingdom

Subscribe to see more

Subscribe to see more

10

5/12/2020

Licensor

SK Biopharmaceuticals

South Korea

Subscribe to see more

Subscribe to see more

10

3/26/2020

Licensor

SK Biopharmaceuticals

South Korea

Subscribe to see more

Subscribe to see more

10

Date

4/1/2021

1/4/2021

8/17/2020

5/12/2020

3/26/2020

Type

Vendor

Licensor

Partner

Licensor

Licensor

Business Partner

Arvato Systems

SK Biopharmaceuticals

Durbin

SK Biopharmaceuticals

SK Biopharmaceuticals

Country

Germany

South Korea

United Kingdom

South Korea

South Korea

News Snippet

Arvelle Therapeutics implements serialization solution "Arvato CSDB Arvelle Therapeutics Committed to Patients and Healthcare Professionals through the Implementation of the IT Solution "Arvato CSDB".

Arvelle Therapeutics International GmbH entered into a partnership with Arvato Systems for the serialization of `` Cenobamate '' , a potential anti-seizure investigational drug in Europe .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.